To the best of our knowledge, no studies have tested the expression of these four markers in the context of OC after GAL treatment, as this compound is mainly tested in association with neurological disorders and cancers and is associated with neuroprotective effects instead of cytotoxic effects. The gene discussed is GAL; the disease is nervous system disorder.